Evolent Health (EVH) Stock Forecast & Price Target

$4.28 +0.46 (+11.88%)

Closing price 03:59 PM Eastern

Extended Trading

$4.28 0.00 (-0.02%)

As of 04:29 PM Eastern

Compare

Evolent Health - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Moderate Buy

Based on 17 Analyst Ratings

Sell
1

Hold
3

Buy
13

Based on 17 Wall Street analysts who have issued ratings for Evolent Health in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 17 analysts, 1 has given a sell rating, 3 have given a hold rating, and 13 have given a buy rating for EVH.

Consensus Price Target

$6.12
42.72% Upside

According to the 17 analysts' twelve-month price targets for Evolent Health, the average price target is $6.12. The highest price target for EVH is $10.00, while the lowest price target for EVH is $3.00. The average price target represents a forecasted upside of 42.72% from the current price of $4.29.

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Get the Latest News and Ratings for EVH and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Evolent Health and its competitors.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

EVH Analyst Ratings Over Time

Type	Current Forecast 5/7/25 to 5/7/26	1 Month Ago 4/7/25 to 4/7/26	3 Months Ago 2/6/25 to 2/6/26	1 Year Ago 5/7/24 to 5/7/25
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	1 Strong Buy rating(s)
Buy	13 Buy rating(s)	13 Buy rating(s)	12 Buy rating(s)	12 Buy rating(s)
Hold	3 Hold rating(s)	3 Hold rating(s)	1 Hold rating(s)	1 Hold rating(s)
Sell	1 Sell rating(s)	1 Sell rating(s)	1 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$6.12	$6.04	$9.50	$17.71
Forecasted Upside	42.72% Upside	137.27% Upside	233.33% Upside	70.00% Upside
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	Buy

EVH Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

EVH Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Evolent Health Stock vs. The Competition

Type	Evolent Health	Computer and Technology Companies	S&P 500
Consensus Rating Score	2.71	2.30	2.52
Consensus Rating	Moderate Buy	Hold	Moderate Buy
Predicted Upside	57.46% Upside	180.44% Upside	14.04% Upside
News Sentiment Rating	Neutral News See Recent EVH News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export

Date	Brokerage	Analyst	Action	Rating	Price Target	Report Date Upside/Downside
5/7/2026	Needham & Company LLC 4 of 5 stars	Matthew Shea Not Rated	Boost Target	Buy	$4.00 ➝ $5.00	+17.23%
3/27/2026	Weiss Ratings Not Rated		Reiterated Rating	Sell (E+)
3/2/2026	TD Cowen 3 of 5 stars		Reiterated Rating	Buy
3/2/2026	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Wiederhorn Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Outperform	$12.00 ➝ $6.00	+81.00%
2/26/2026	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Daniel Grosslight Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Buy	$6.00 ➝ $4.00	+19.94%
2/26/2026	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kevin Caliendo Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Buy	$10.00 ➝ $5.00	+53.14%
2/25/2026	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jailendra Singh Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Buy	$10.00 ➝ $6.00	+96.40%
2/25/2026	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Sean Dodge Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Outperform	$3.50	+14.45%
2/25/2026	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ryan Halsted Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Sector Perform	$5.00 ➝ $3.00	-3.69%
2/25/2026	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David Larsen Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Buy	$10.00 ➝ $8.00	+213.11%
Get the Latest News and Ratings for EVH and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Evolent Health and its competitors with MarketBeat's FREE daily newsletter.
2/25/2026	KeyCorp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Matthew Gillmor Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Downgrade	Overweight ➝ Sector Weight
1/6/2026	Citizens Jmp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Constantine Davides Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Market Outperform	$11.00 ➝ $10.00	+152.21%
12/2/2025	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jessica Tassan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Set Target		$6.00	+54.44%
11/17/2025	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Anne Samuel Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Overweight	$13.00 ➝ $7.00	+75.22%
11/14/2025	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Richard Close Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Buy	$16.00 ➝ $9.00	+113.52%
11/13/2025	Stephens Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jeff Garro Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade	Equal Weight ➝ Overweight	$7.00	+54.02%
11/10/2025	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Upgrade	Strong Sell ➝ Hold
11/11/2024	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Lower Target	Overweight	$39.00 ➝ $19.00	+37.68%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Thursday at 05:01 PM ET.

EVH Forecast - Frequently Asked Questions

: According to the research reports of 17 Wall Street equities research analysts, the average twelve-month stock price forecast for Evolent Health is $6.12, with a high forecast of $10.00 and a low forecast of $3.00.
: 17 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Evolent Health in the last year. There is currently 1 sell rating, 3 hold ratings and 13 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" EVH shares.
: According to analysts, Evolent Health's stock has a predicted upside of 42.72% based on their 12-month stock forecasts.
: Over the previous 90 days, Evolent Health's stock had 1 downgrade by analysts.
: Evolent Health has been rated by research analysts at BMO Capital Markets, BTIG Research, Citigroup, KeyCorp, Needham & Company LLC, Oppenheimer, Royal Bank Of Canada, TD Cowen, Truist Financial, UBS Group, and Weiss Ratings in the past 90 days.
: Analysts like Evolent Health more than other "computer and technology" companies. The consensus rating for Evolent Health is Moderate Buy while the average consensus rating for "computer and technology" companies is Hold. Learn more on how EVH compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With Evolent Health Recommendations

This page (NYSE:EVH) was last updated on 5/7/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Evolent Health (EVH) Stock Forecast & Price Target

Evolent Health - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Consensus Price Target

EVH Analyst Ratings Over Time

EVH Analyst Recommendations By Month

EVH Price Targets by Month

Evolent Health Stock vs. The Competition

Recent Analyst Forecasts and Stock Ratings

EVH Forecast - Frequently Asked Questions

Stock Forecasts and Research Tools

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With Evolent Health Recommendations

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Evolent Health (EVH) Stock Forecast & Price Target

Evolent Health - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Consensus Price Target

EVH Analyst Ratings Over Time

EVH Analyst Recommendations By Month

EVH Price Targets by Month

Evolent Health Stock vs. The Competition

Recent Analyst Forecasts and Stock Ratings

EVH Forecast - Frequently Asked Questions

Stock Forecasts and Research Tools

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With Evolent Health Recommendations

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools